Allosteric modulation of GPCR-induced β-arrestin trafficking and signaling by a synthetic intrabody
G protein-coupled receptors (GPCRs) are integral membrane proteins and the largest class of drug targets in the human genome. Here, Baidya et al. show that a synthetic antibody can be used to modulate GPCR trafficking and signaling in live cells.
Autori principali: | , , , , , , , , , , , , , , , , , , , |
---|---|
Natura: | Articolo |
Lingua: | English |
Pubblicazione: |
Nature Portfolio
2022-08-01
|
Serie: | Nature Communications |
Accesso online: | https://doi.org/10.1038/s41467-022-32386-x |